Analysis of online cancer genomics resources reveals that MRNIP is downregulated in several cancers, including head and neck squamous cell carcinoma, and amplified in 18% of renal clear cell carcinomas, which may be worth further study. The gene discussed is MRNIP; the disease is cancer.